References
-
1) Live-cell imaging-based dynamic vascular formation assay for antivascular drug evaluation and screening.
-
2) Dynamic nanoassemblies derived from small-molecule homodimeric prodrugs for in situ drug activation and safe osteosarcoma treatment.
-
3) Copper overload impairs hematopoietic stem and progenitor cell proliferation via prompting HSF1/SP1 aggregation and the subsequently downregulating FOXM1-Cytoskeleton axis.
-
4) ALKBH5-mediated m6A demethylation of HS3ST3B1-IT1 prevents osteoarthritis progression.
-
5) 3D-printed scaffold harboring copper ions combined with near-infrared irradiation for local therapy of cancer.
-
6) A micro-electroporation/electrophoresis-based vaccine screening system reveals the impact of vaccination orders on cross-protective immunity.
-
7) Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport.
-
8) Preclinical efficacy of TZG in myofascial pain syndrome by impairing PI3K-RAC2 signaling-mediated neutrophil extracellular traps.
-
9) Lupeol synergizes with 5-fluorouracil to combat c-MET/EphA2 mediated chemoresistance in triple negative breast cancer.
-
10) Stromal and tumor immune microenvironment reprogramming through multifunctional cisplatin-based liposomes boosts the efficacy of anti-PD-1 immunotherapy in pancreatic cancer.
-
11) Enhanced brain delivery of hypoxia-sensitive liposomes by hydroxyurea for rescue therapy of hyperacute ischemic stroke.
-
12) Deciphering postnatal limb development at single-cell resolution.
-
13) Single-cell transcriptomics reveals ependymal subtypes related to cytoskeleton dynamics as the core driver of syringomyelia pathological development.
-
14) Identification of S1PR4 as an immune modulator for favorable prognosis in HNSCC through machine learning.
-
15) GNPNAT1 is a potential biomarker correlated with immune infiltration and immunotherapy outcome in breast cancer.